Sample	O
Type	O
/	O
Medical	O
Specialty	O
:	O
General	O
Medicine	O

Sample	O
Name	O
:	O
Medical	O
Management	O
Consult	O
Request	O

Description	O
:	O
Patient	O
with	O
Hypertension	B-problem
,	O
atrial	B-bodyloc
fibrillation	I-problem
,	O
large	B-problem
cardioembolic	I-problem
stroke	I-problem
initially	O
to	O
the	O
right	B-bodyloc
brain	I-bodyloc
requesting	O
medical	B-treatment
management	I-treatment

(	O
Medical	O
Transcription	O
Sample	O
Report	O
)	O

CONSULT	O
REQUEST	O
FOR	O
:	O
Medical	B-treatment
management	I-treatment
.	O

The	O
patient	O
has	O
been	O
in	O
special	B-treatment
procedures	I-treatment
now	B-temporal
for	O
over	O
2	O
hours	O
and	O
I	O
am	O
unable	O
to	O
examine	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O
Obtained	O
from	O
Dr	O
.	O
A	O
on	O
an	O
81	O
-	O
year	O
-	O
old	O
white	O
female	O
,	O
who	O
is	O
right	O
handed	O
,	O
who	O
by	O
history	O
,	O
had	O
a	B-problem
large	I-problem
stroke	I-problem
to	I-problem
the	I-problem
right	B-bodyloc
brain	I-bodyloc
,	O
causing	O
left	O
body	O
findings	O
,	O
last	B-temporal
night	I-temporal
.	O

She	O
was	O
unfortunately	O
outside	O
of	O
the	O
window	O
for	O
emergent	B-treatment
treatment	I-treatment
and	O
had	O
a	O
negative	B-labvalue
CT	B-test
scan	I-test
of	I-test
the	I-test
head	I-test
.	O

Was	O
started	O
on	O
protocol	B-drug
medication	I-drug
and	O
that	O
is	O
similar	O
to	O
TPA	B-drug
,	O
which	O
is	O
an	B-test
investigational	I-test
study	I-test
.	O

During	O
the	B-test
evaluation	I-test
she	O
was	O
found	O
to	O
be	O
in	O
atrial	B-bodyloc
fibrillation	I-problem
on	O
admission	O
with	O
hypertension	B-problem
that	O
was	O
treated	O
with	O
labetalol	B-drug
en	O
route	O
.	O

Her	B-test
heart	I-test
rate	I-test
was	O
130	B-labvalue
.	O

She	O
was	O
brought	O
down	O
with	O
Cardizem	B-drug
.	O

She	O
received	O
the	B-treatment
study	I-treatment
drug	I-treatment
in	O
the	B-temporal
night	I-temporal
and	O
about	O
an	O
hour	O
later	O
thought	O
to	O
have	O
another	B-problem
large	I-problem
stroke	I-problem
effecting	O
the	O
opposite	B-bodyloc
side	I-bodyloc
of	I-bodyloc
the	I-bodyloc
brain	I-bodyloc
,	O
that	O
the	O
doctors	O
and	O
company	O
think	O
is	O
probably	B-uncertain
cardioembolic	B-problem
and	O
not	O
related	O
to	O
the	B-treatment
study	I-treatment
drug	I-treatment
,	O
as	O
TPA	B-drug
has	O
no	O
obvious	O
known	O
association	O
with	O
this	O
.	O

At	O
that	O
time	O
the	O
patient	O
became	O
comatose	B-problem
and	O
required	O
emergent	B-treatment
intubation	I-treatment
and	O
paralyzation	B-problem
.	O

Her	B-test
diastolic	I-test
at	O
that	O
time	O
rose	O
up	O
to	O
190	B-labvalue
,	O
likely	O
the	O
result	O
of	O
the	B-problem
acute	B-course
second	I-problem
stroke	I-problem
.	O

She	O
is	O
currently	B-temporal
in	O
arteriogram	B-test
and	O
a	B-problem
clot	I-problem
has	O
been	O
extracted	O
from	O
the	O
proximal	B-bodyloc
left	I-bodyloc
carotid	I-bodyloc
,	O
but	O
there	O
is	O
still	O
distal	B-problem
clot	I-problem
that	O
they	O
are	O
working	O
on	O
.	O

Dr	O
.	O
A	O
has	O
updated	O
the	O
family	O
to	O
her	O
extremely	O
guarded	O
and	O
critical	O
prognosis	O
.	O

At	O
present	O
,	O
it	O
is	O
not	O
known	O
yet	O
,	O
we	O
do	O
not	O
have	O
the	B-test
STAT	I-test
echocardiogram	I-test
,	O
if	B-condition
she	O
has	O
a	B-problem
large	I-problem
clot	I-problem
in	I-problem
the	I-problem
heart	B-bodyloc
or	O
if	B-condition
she	O
could	O
have	O
a	B-problem
patent	I-problem
foramen	B-bodyloc
ovale	I-bodyloc
clot	I-problem
in	I-problem
the	I-problem
legs	B-bodyloc
that	O
has	O
been	O
passed	O
to	O
the	O
heart	O
.	O

Echo	B-test
that	O
is	O
pending	O
,	O
and	O
cannot	O
be	O
done	O
till	O
the	O
patient	O
is	O
out	O
of	O
arteriogram	B-test
,	O
which	O
is	O
her	B-treatment
lifesaving	I-treatment
procedure	I-treatment
right	B-temporal
now	I-temporal
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O
Complete	O
review	O
of	O
systems	O
is	O
unobtainable	O
at	O
present	O
.	O

From	O
what	O
I	O
can	O
tell	O
,	O
is	O
that	O
she	O
is	O
scheduled	O
for	O
an	B-treatment
upcoming	I-treatment
bladder	I-treatment
distension	I-treatment
surgery	I-treatment
and	O
I	O
do	O
not	O
know	O
if	O
this	O
is	O
why	O
she	O
is	O
off	O
Coumadin	B-drug
for	O
chronic	B-course
AFib	I-problem
or	O
what	O
,	O
at	O
this	O
point	O
.	O

Tremor	B-problem
for	O
3	B-temporal
-	I-temporal
4	I-temporal
years	I-temporal
,	O
diagnosed	O
as	O
early	B-problem
Parkinson	I-problem
'	I-problem
s	I-problem
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O
GERD	B-problem
,	O
hypertension	B-problem
times	O
20	B-temporal
years	I-temporal
,	O
arthritis	B-problem
,	O
Parkinson	B-problem
'	I-problem
s	I-problem
,	O
TIA	B-problem
,	O
chronic	B-course
atrial	B-bodyloc
fibrillation	I-problem
,	O
on	O
Coumadin	B-drug
three	B-duration
years	I-duration
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O
Cholecystectomy	B-treatment
,	O
TAH	B-treatment
33	O
,	O
gallstones	B-problem
,	O
back	B-treatment
surgery	I-treatment
1998	B-temporal
,	O
thoracotomy	B-treatment
for	O
unknown	O
reason	O
at	O
present	O
.	O

ALLERGIES	O
:	O
MORPHINE	B-drug
,	O
SULFAS	B-drug
(	O
RASH	B-problem
)	O
,	O
PROZAC	B-drug
.	O

MEDICATIONS	O
AT	O
HOME	O
:	O
Lanoxin	B-drug
0	B-strength
.	I-strength
25	I-strength
daily	B-frequency
;	O
Inderal	B-drug
LA	I-drug
80	B-strength
daily	B-frequency
;	O
MOBIC	B-drug
7	B-strength
.	I-strength
5	I-strength
daily	B-frequency
;	O
Robaxin	B-drug
750	B-strength
q	B-frequency
.	I-frequency
8	I-frequency
;	O
aspirin	B-drug
80	B-strength
one	B-dosage
daily	B-frequency
;	O
acyclovir	B-drug
dose	O
unknown	O
daily	B-frequency
;	O
potassium	B-drug
,	O
dose	O
unknown	O
;	O
oxazepam	B-drug
15	B-strength
mg	I-strength
daily	B-frequency
;	O
aspirin	B-drug
80	B-strength
one	B-dosage
daily	B-frequency
;	O
ibuprofen	B-drug
PRN	B-frequency
;	O
Darvocet	B-drug
-	I-drug
N	I-drug
100	B-strength
PRN	B-frequency
.	O

SOCIAL	O
HISTORY	O
:	O
She	O
does	O
not	O
drink	O
or	O
smoke	O
.	O

Lives	O
in	O
Fayetteville	O
,	O
Tennessee	O
.	O

FAMILY	O
HISTORY	O
:	O
Mother	B-subject
died	O
of	O
cancer	B-problem
,	O
unknown	O
type	O
.	O

Dad	B-subject
died	O
of	O
an	B-problem
MI	I-problem
.	O

VACCINATION	O
STATUS	O
:	O
Unknown	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

VITAL	O
SIGNS	O
:	O
On	O
arrival	O
were	O
temperature	B-test
97	B-labvalue
.	I-labvalue
1	I-labvalue
,	O
blood	B-test
pressure	I-test
174	B-labvalue
/	I-labvalue
100	I-labvalue
,	O
heart	B-test
rate	I-test
100	B-labvalue
,	O
97	O
%	O
,	O
respirations	B-test
15	B-labvalue
.	O

GENERAL	O
:	O
She	O
was	O
apparently	O
alert	O
and	O
able	O
to	O
give	O
history	O
on	O
arrival	O
.	O

Currently	O
do	B-negation
not	I-negation
have	I-negation
any	O
available	O
vital	B-test
signs	I-test
or	O
physical	B-test
exam	I-test
,	O
as	O
I	O
cannot	O
get	O
to	O
the	O
patient	O
.	O

LABORATORY	O
:	O
Reviewed	O
and	O
are	O
remarkable	O
for	O
white	B-test
count	I-test
of	O
13	B-labvalue
with	O
76	B-labvalue
neutrophils	B-test
.	O

BMP	B-test
is	O
normal	B-labvalue
,	O
except	O
for	O
a	B-test
blood	I-test
sugar	I-test
of	O
157	B-labvalue
,	O
hemoglobin	B-test
A1c	I-test
is	O
pending	O
.	O

TSH	B-test
2	B-labvalue
.	I-labvalue
1	I-labvalue
,	O
cholesterol	B-test
165	B-labvalue
,	O
Digoxin	B-test
1	B-labvalue
.	I-labvalue
24	I-labvalue
,	O
CPK	B-test
57	B-labvalue
.	O

ABG	B-test
7	B-labvalue
.	I-labvalue
47	I-labvalue
/	I-labvalue
32	I-labvalue
/	I-labvalue
459	I-labvalue
on	O
100	O
%	O
.	O

Magnesium	B-test
1	B-labvalue
.	I-labvalue
5	I-labvalue
.	O

ESR	B-test
9	B-labvalue
,	O
coags	B-test
normal	B-labvalue
.	O

EKG	B-test
is	O
pending	O
my	O
review	O
.	O

Chest	B-test
x	I-test
-	I-test
ray	I-test
is	O
read	O
as	O
mild	B-severity
cardiomegaly	I-problem
and	O
atherosclerotic	B-problem
aorta	B-bodyloc
.	O

Chest	B-test
x	I-test
-	I-test
ray	I-test
,	O
shoulder	B-test
films	I-test
and	O
CT	B-test
scan	I-test
of	I-test
the	I-test
head	I-test
:	O
I	O
have	O
reviewed	O
.	O

Chest	B-test
x	I-test
-	I-test
ray	I-test
has	O
good	O
ET	B-treatment
tube	I-treatment
placement	I-treatment
.	O

She	O
has	O
mild	B-severity
cardiomegaly	I-problem
.	O

Some	B-problem
mild	B-severity
interstitial	I-problem
opacities	I-problem
consistent	O
with	O
OGD	B-problem
and	O
minimal	B-severity
amount	I-severity
of	O
atherosclerosis	B-problem
of	I-problem
the	I-problem
aorta	B-bodyloc
.	O

CT	B-test
scan	I-test
of	I-test
the	I-test
head	I-test
:	O
I	O
do	B-negation
not	I-negation
see	I-negation
any	B-problem
active	I-problem
bleeding	I-problem
.	O

X	B-test
-	I-test
rays	I-test
of	I-test
the	I-test
shoulders	I-test
appear	O
intact	B-labvalue
to	O
me	O
and	O
we	O
are	O
awaiting	O
radiologies	O
final	O
approval	O
on	O
those	O
.	O

ASSESSMENT	O
/	O
PLAN	O
/	O
PROBLEMS	O
:	O

1	O
.	O

Large	B-problem
cardioembolic	I-problem
stroke	I-problem
initially	O
to	O
the	O
right	B-bodyloc
brain	I-bodyloc
,	O
with	O
devastating	B-problem
effects	I-problem
,	O
and	O
now	B-temporal
stroke	B-problem
into	I-problem
the	I-problem
left	B-bodyloc
brain	I-bodyloc
as	O
well	O
,	O
with	O
fluctuating	B-problem
mental	I-problem
status	I-problem
.	O

Obviously	O
she	O
is	O
in	O
critical	O
condition	O
and	O
stable	B-course
with	O
multiple	B-problem
strokes	I-problem
.	O

One	O
must	O
also	O
wonder	O
if	B-condition
she	O
could	O
have	O
a	B-problem
large	I-problem
clot	I-problem
burden	I-problem
below	I-problem
the	I-problem
heart	B-bodyloc
and	O
patent	B-problem
foramen	B-bodyloc
ovale	I-bodyloc
,	O
etc	O
.	O

We	O
need	O
STAT	O
records	O
from	O
her	O
prior	O
cardiologist	O
and	O
prior	B-temporal
echocardiogram	B-test
report	O
to	O
see	O
exactly	O
what	O
are	O
the	O
details	O
.	O

I	O
have	O
ordered	O
a	B-test
STAT	I-test
echo	I-test
and	O
to	O
have	O
the	O
group	O
that	O
sees	O
her	O
read	O
it	O
,	O
that	O
if	O
he	O
has	O
a	B-problem
large	I-problem
clot	I-problem
burdened	I-problem
in	I-problem
the	I-problem
heart	B-bodyloc
or	O
has	O
distal	B-problem
clot	I-problem
with	O
a	B-problem
PFO	I-problem
we	O
may	O
be	O
able	O
to	O
better	O
prognosticate	O
at	O
this	O
point	O
.	O

Obviously	O
,	O
she	O
cannot	B-negation
have	I-negation
any	B-treatment
anticoagulants	I-treatment
,	O
except	O
for	O
the	B-treatment
study	I-treatment
drug	I-treatment
,	O
at	O
present	O
,	O
which	O
is	O
her	O
only	O
chance	O
and	O
hopefully	O
they	O
will	O
be	O
able	O
to	O
retrieve	O
most	O
of	O
the	B-problem
clot	I-problem
with	O
emergency	B-treatment
retrieval	I-treatment
device	I-treatment
as	O
activated	O
heroically	O
,	O
by	O
Dr	O
.	O
A	O
and	O
interventional	O
radiology	O
.	O

2	O
.	O

Hypertension	B-problem
/	O
atrial	B-bodyloc
fibrillation	I-problem
:	O
This	O
will	O
be	O
a	O
difficult	O
management	O
and	O
the	O
fact	O
that	O
she	O
has	O
been	O
on	O
a	B-drug
beta	I-drug
-	I-drug
blocker	I-drug
for	O
Parkinson	B-problem
'	I-problem
s	I-problem
,	O
she	O
may	O
have	O
withdrawal	O
to	O
the	B-drug
beta	I-drug
-	I-drug
blockers	I-drug
as	O
we	O
remove	O
this	O
.	O

Given	O
her	B-problem
atrial	B-bodyloc
fibrillation	I-problem
,	O
I	O
do	O
agree	O
the	O
safest	O
agent	O
right	O
now	O
is	O
to	O
use	O
a	O
Cardizem	B-drug
drip	B-route
as	B-frequency
needed	I-frequency
and	O
would	O
use	O
it	O
for	O
systolic	B-test
greater	O
than	O
160	O
to	O
180	O
,	O
or	O
diastolics	B-test
greater	O
than	O
90	O
to	O
100	O
.	O

Also	O
,	O
would	O
use	O
it	O
to	O
control	O
the	B-problem
atrial	B-bodyloc
fibrillation	I-problem
.	O

We	O
would	O
,	O
however	O
,	O
be	O
very	O
cautious	O
not	O
to	O
put	O
her	O
in	O
heart	B-bodyloc
block	I-problem
with	O
the	B-drug
Digoxin	I-drug
and	O
the	B-drug
beta	I-drug
-	I-drug
blocker	I-drug
on	O
board	O
.	O

Weighing	O
all	O
risks	O
and	O
benefits	O
,	O
I	O
think	O
that	O
given	O
the	O
fact	O
that	O
she	O
has	O
a	B-drug
beta	I-drug
-	I-drug
blocker	I-drug
on	O
board	O
and	O
Digoxin	B-drug
,	O
we	O
would	O
like	O
to	O
avoid	B-negation
the	B-drug
beta	I-drug
-	I-drug
blocker	I-drug
for	O
vasospasm	B-treatment
protection	I-treatment
and	O
will	O
favor	O
using	O
calcium	B-drug
channel	I-drug
blocker	I-drug
for	O
now	B-temporal
.	O

If	O
,	O
however	O
,	O
we	O
run	O
into	O
trouble	O
with	O
this	O
,	O
I	O
would	O
prefer	O
to	O
switch	O
her	O
to	O
Brevibloc	B-drug
or	O
an	B-drug
Esmolol	I-drug
drip	B-route
and	O
see	O
how	O
she	O
does	O
,	O
as	O
she	O
may	O
withdraw	O
from	O
the	B-drug
beta	I-drug
-	I-drug
blocker	I-drug
.	O

I	O
will	O
be	O
watching	O
this	O
closely	O
and	O
managing	O
the	B-problem
hypertension	I-problem
as	O
I	O
see	O
fit	O
at	O
the	O
moment	O
,	O
based	O
on	O
all	O
factors	O
.	O

Will	O
also	O
ask	O
cardiology	O
if	O
she	O
has	O
one	O
that	O
sees	O
her	O
here	O
,	O
to	O
help	O
guide	O
this	O
.	O

Her	B-test
Digoxin	I-test
level	I-test
is	O
appropriate	O
,	O
as	O
well	O
as	O
a	B-test
TSH	I-test
.	O

I	O
do	O
not	O
feel	O
that	O
we	O
need	O
to	O
work	O
this	O
up	O
further	O
,	O
other	O
than	O
the	B-test
STAT	I-test
echo	I-test
and	O
ultrasound	B-test
of	I-test
the	I-test
leg	I-test
.	O

3	O
.	O

Respiratory	B-bodyloc
failure	I-problem
requiring	O
ventilator	B-treatment
:	O
I	O
have	O
discussed	O
this	O
with	O
Dr	O
.	O
Devlin	O
,	O
we	O
do	O
not	O
feel	O
the	O
need	O
to	O
hyperventilate	O
her	O
at	O
present	O
.	O

We	O
will	O
keep	O
her	O
comfortable	O
on	O
the	B-treatment
breathing	I-treatment
machine	I-treatment
and	O
try	O
to	O
keep	O
her	B-test
pH	I-test
in	O
a	B-labvalue
normal	I-labvalue
range	I-labvalue
,	O
around	O
7	O
.	O
4	O
,	O
and	O
her	B-test
CO2	I-test
in	O
the	O
30	B-labvalue
to	I-labvalue
40	I-labvalue
range	I-labvalue
.	O

If	B-condition
she	O
has	O
brain	B-bodyloc
swelling	I-problem
,	O
we	O
will	O
need	O
to	O
hyperventilate	O
her	O
to	O
a	B-test
pCO2	I-test
of	O
30	B-labvalue
and	O
a	B-test
pH	I-test
of	O
7	B-labvalue
.	I-labvalue
5	I-labvalue
,	O
to	O
optimize	O
the	B-problem
cardiac	B-bodyloc
arrhythmia	I-problem
potential	O
of	O
alkalosis	B-problem
weighed	O
with	O
the	O
control	O
of	O
brain	B-bodyloc
swelling	I-problem
.	O

4	O
.	O

Optimize	O
electrolytes	B-test
as	O
you	O
can	O
.	O

5	O
.	O

Deep	B-treatment
vein	I-treatment
thrombosis	I-treatment
prophylaxis	I-treatment
for	O
now	B-temporal
,	O
with	O
thigh	B-treatment
-	I-treatment
high	I-treatment
TED	I-treatment
hose	I-treatment
,	O
possibly	B-uncertain
SCDs	B-problem
,	O
although	O
I	O
do	O
not	O
have	O
experience	O
with	O
the	O
vampire	O
/	O
venom	O
to	O
know	O
if	O
we	O
need	O
to	O
worry	O
about	O
DIC	B-problem
which	O
the	B-problem
SCDs	I-problem
may	O
worsen	B-course
.	O

Will	O
follow	O
daily	O
CBCs	B-test
for	O
that	O
.	O

6	O
.	O

Nutrition	O
:	O
Will	O
go	O
ahead	O
and	O
start	O
a	O
low	O
dose	O
of	O
tube	B-treatment
feeds	I-treatment
and	O
hope	O
that	O
she	O
does	O
survive	O
.	O

I	O
will	O
defer	O
all	O
updates	O
to	O
the	O
family	O
for	O
the	O
next	O
24	O
to	O
48	O
hours	O
to	O
Dr	O
.	O
Devlin	O
'	O
s	O
expertise	O
,	O
given	O
her	O
unknown	O
and	O
fluctuating	O
neurologic	O
prognosis	O
.	O

Thank	O
you	O
so	O
much	O
for	O
allowing	O
us	O
to	O
participate	O
in	O
her	O
care	O
.	O

We	O
will	O
be	O
happy	O
to	O
do	O
all	B-treatment
medication	I-treatment
treatment	I-treatment
until	O
the	O
point	O
that	O
I	O
feel	O
that	O
I	O
would	O
need	O
any	O
help	O
from	O
critical	O
care	O
.	O

I	O
believe	O
that	O
we	O
will	O
be	O
able	O
to	O
manage	O
her	O
fully	O
at	O
this	O
point	O
,	O
for	O
simplicity	O
sake	O
.	O

Keywords	O
:	O

general	O
medicine	O
,	O
medical	B-treatment
management	I-treatment
consult	O
request	O
,	O
medical	B-treatment
management	I-treatment
consult	O
,	O
management	O
consult	O
request	O
,	O
review	O
of	O
systems	O
,	O
chest	B-test
x	I-test
ray	I-test
,	O
consult	O
request	O
,	O
foramen	O
ovale	O
,	O
medical	O
management	O
,	O
ct	B-test
scan	I-test
,	O
atrial	O
,	O
echocardiogram	B-test
,	O
fibrillation	B-problem
,	O
heart	O
,	O
clot	B-problem
,	O

